Christos Kampolis
EIP on AHA Greek Network
Christos Kampolis
I am a Medical Doctor specialized in Respiratory Medicine since 2012. My clinical work has focused on patients with systemic autoimmune disease and pulmonary co-morbidities and the management of patients with respiratory failure in the Emergency Department and Intensive Care Unit setting. During the peak of COVID-19 pandemic, I was also one of the sub-coordinators of the COVID-19 clinic and the Emergency Department of “Hippokrateion” General Hospital of Athens.
Furthermore, I have participated as a research associate in projects funded on a European level in the field of chronic disease
management in multimorbid patients. I have also experience in statistics and am a teacher in three National
MSc programs focusing on respiratory and intensive care medicine.
Since 2020, I have been working as a consultant in Respiratory Medicine at the Emergency Department of “Hippokrateion” General Hospital of Athens. In recent years, I have been clinically involved in the “Frontizo” Integrated Care Program (https://iatreia.cityofathens.gr/programma-frontizo/), which is designed to support socio-economically vulnerable citizens of the Municipality of Athens who suffer from chronic diseases.
FURTHER INFORMATION
| Countries | Greece; |
|---|---|
| Topics | Care innovations; Care trajectories; Climate Change and LTC; Community-based LTC; Implementation; Loneliness among older people; LTC systems in LMIC countries; Social Prescribing; Technology and LTC; |
| Methods | Case studies; Literature reviews and synthesis; Observational studies; Surveys; Systematic Review; |
| Role | Advocacy; |
| Interest Groups | Ageing and Place; Climate Change and LTC; Integrated Long-Term Care; Technology and Long-Term Care; |
| GOOGLE SCHOLAR | https://scholar.google.com/scholar?hl=el&as_sdt=0,5&q=christos+kampolis |
| Other 1 | https://iatreia.cityofathens.gr/programma-frontizo/; |
| Research interests | My research work has focused on patients with systemic autoimmune disease and pulmonary co-morbidities and |
| Key publications | 1. Kampolis C, Tektonidou M, Moyssakis I, Tzelepis GE, Moutsopoulos H, Vlachoyiannopoulos PG. Evolution of cardiac dysfunction in patients with antiphospholipid antibodies and/or antiphospholipid 2. Jennifer McIntosh, Albert Alonso, Katie MacLure, Derek Stewart, Thomas Kempen, Alpana Mair, Margarida Castel-Branco, Carles Codina, Fernando Fernandez-Llimos, Glenda Fleming, Dimitra Gennimata, Ulrika Gillespie, Cathy Harrison, Maddalena Illario, Ulrike Junius-Walker, Christos F. Kampolis, Przemyslaw Kardas, Pawel Lewek, João Malva, Enrica Menditto, Claire Scullin, Birgitt Wiese, on behalf of the SIMPATHY Consortium. A case study of polypharmacy management in nine European countries: implications for change management and implementation. PLoS One. 2018 Apr 18;13(4):e0195232 3. Kampolis CF, Mermiri M, Mavrovounis G, Koutsoukou A, Loukeri AA, Pantazopoulos I. Comparison of advanced closed-loop ventilation modes with pressure support ventilation for weaning from mechanical ventilation in adults: A systematic review and meta-analysis. J Crit Care. 2022 Apr;68:1-9. 4. Athanasios Chalkias, Ioannis Pantazopoulos, Nikolaos Papagiannakis, Anargyros Skoulakis, Eleni Laou, Konstantina Kolonia, Nicoletta Ntalarizou, Konstantinos Tourlakopoulos, Athanasios Pagonis, Christos Kampolis, Luis García De Guadiana Romualdo, Dimitrios Ragias, Jesper Eugen-Olsen, Konstantinos Gourgoulianis, Eleni Arnaoutoglou, SPARCOL Investigators. Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage. Toxicol Rep. 2021;8:1394-1398. |